B. Riley Wealth Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,588
| Closed | -$205K | – | 1548 |
|
|
2024
Q1 | $205K | Buy |
+3,588
| New | +$233K | 0.01% | 1265 |
|
|
2023
Q4 | – | Sell |
-3,588
| Closed | -$205K | – | 1481 |
|
|
2023
Q3 | $205K | Sell |
3,588
-160
| -4% | -$9.76K | 0.01% | 1265 |
|
|
2023
Q2 | $230K | Sell |
3,748
-150
| -4% | -$9.36K | 0.01% | 1278 |
|
|
2023
Q1 | $245K | Sell |
3,898
-115
| -3% | -$7.41K | 0.01% | 1182 |
|
|
2022
Q4 | $255K | Sell |
4,013
-22
| -0.5% | -$1.4K | 0.01% | 1126 |
|
|
2022
Q3 | $238K | Buy |
4,035
+47
| +1% | +$2.9K | 0.01% | 1140 |
|
|
2022
Q2 | $231K | Sell |
3,988
-549
| -12% | -$31.6K | 0.01% | 980 |
|
|
2022
Q1 | $282K | Sell |
4,537
-321
| -7% | -$19.6K | 0.01% | 1041 |
|
|
2021
Q4 | $346K | Sell |
4,858
-55
| -1% | -$3.98K | 0.01% | 997 |
|
|
2021
Q3 | $368K | Hold |
4,913
| – | – | 0.01% | 932 |
|
|
2021
Q2 | $380K | Buy |
4,913
+60
| +1% | +$4.46K | 0.01% | 904 |
|
|
2021
Q1 | $359K | Sell |
4,853
-5
| -0.1% | -$378 | 0.01% | 905 |
|
|
2020
Q4 | $341K | Buy |
4,858
+20
| +0.4% | +$1.27K | 0.02% | 688 |
|
|
2020
Q3 | $274K | Sell |
4,838
-131
| -3% | -$7.7K | 0.01% | 735 |
|
|
2020
Q2 | $290K | Buy |
4,969
+38
| +0.8% | +$2.07K | 0.02% | 644 |
|
|
2020
Q1 | $230K | Sell |
4,931
-811
| -14% | -$42.3K | 0.02% | 623 |
|
|
2019
Q4 | $321K | Sell |
5,742
-15
| -0.3% | -$782 | 0.03% | 571 |
|
|
2019
Q3 | $273K | Sell |
5,757
-372
| -6% | -$19.1K | 0.03% | 623 |
|
|
2019
Q2 | $328K | Sell |
6,129
-9,014
| -60% | -$468K | 0.04% | 526 |
|
|
2019
Q1 | $836K | Buy |
15,143
+336
| +2% | +$17.8K | 0.1% | 218 |
|
|
2018
Q4 | $697K | Buy |
14,807
+9,077
| +158% | +$467K | 0.1% | 221 |
|
|
2018
Q3 | $341K | Buy |
5,730
+1,053
| +23% | +$61.4K | 0.04% | 453 |
|
|
2018
Q2 | $256K | Buy |
4,677
+515
| +12% | +$26.2K | 0.03% | 528 |
|
|
2018
Q1 | $205K | Buy |
+4,162
| New | +$212K | 0.03% | 581 |
|
|
2016
Q4 | – | Sell |
-15,726
| Closed | -$660K | – | 607 |
|
|
2016
Q3 | $660K | Buy |
15,726
+598
| +4% | +$24.6K | 0.13% | 196 |
|
|
2016
Q2 | $560K | Buy |
15,128
+2,065
| +16% | +$81K | 0.11% | 221 |
|
|
2016
Q1 | $500K | Sell |
13,063
-790
| -6% | -$30.7K | 0.12% | 225 |
|
|
2015
Q4 | $700K | Buy |
13,853
+1,493
| +12% | +$73.8K | 0.14% | 181 |
|
|
2015
Q3 | $566K | Buy |
12,360
+6,593
| +114% | +$368K | 0.14% | 210 |
|
|
2015
Q2 | $337K | Buy |
+5,767
| New | +$330K | 0.08% | 305 |
|
|
2015
Q1 | – | Sell |
-1,620
| Closed | -$81 | – | 1554 |
|
|
2014
Q4 | $81 | Buy |
+1,620
| New | +$79.3K | ﹤0.01% | 1836 |
|
|
2014
Q3 | – | Sell |
-1,241
| Closed | -$54.3K | – | 1511 |
|
|
2014
Q2 | $54.3K | Buy |
+1,241
| New | +$50.3K | 0.01% | 995 |
|
Other funds holding PBE
GKWIM
CW
OCM
B. Riley Wealth Advisors's PBE Position: Q2 2024 in Review
B. Riley Wealth Advisors sold out of Invesco Biotechnology & Genome ETF (PBE) in Q2 2024, closing a stake of 3,588 shares — an estimated $205K sold.
B. Riley Wealth Advisors first reported a position in PBE in Q2 2014 and held it in 32 quarters. The position peaked at $836K in Q1 2019. 100 funds tracked by Wall St. Rank hold PBE as of Q2 2024.
- B. Riley Wealth Advisors reported no remaining Invesco Biotechnology & Genome ETF position as of Q2 2024 after selling out during the quarter.
- B. Riley Wealth Advisors sold 3,588 Invesco Biotechnology & Genome ETF shares in Q2 2024, an estimated $205K.
- B. Riley Wealth Advisors first reported a position in Invesco Biotechnology & Genome ETF in Q2 2014 and held it in 32 quarters.
- B. Riley Wealth Advisors's Invesco Biotechnology & Genome ETF position peaked at $836K in Q1 2019.
- 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2024.
Based on B. Riley Wealth Advisors's 13F filing for Q2 2024, filed 19 Aug 2024.